Inner Mongolia Medical University is a university in Inner Mongolia, under the authority of the Autonomous Region government. It is in Hohhot, the capital city of Inner Mongolia Autonomous Region. It was renamed from Inner Mongolia Medical College in 2012.

During the past decade, The Affiliated Hospital of Inner Mongolia Medical University conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Affiliated Hospital of Inner Mongolia Medical University" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Chinese SLE Treatment And Research Group" with 3 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Peking University First Hospital" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Affiliated Hospital of Inner Mongolia Medical University" #1 collaborator was "The Affiliated Hospital of Inner Mongolia Medical University" with 5 trials as a collaborator, "The Second Hospital of Hebei Medical University" with 4 trials as a collaborator, "Daqing Oil Field Hospital" with 2 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 2 trials as a collaborator and "Henan Provincial People's Hospital" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "The Affiliated Hospital of Inner Mongolia Medical University" are "Rheumatoid Arthritis" (3 trials), "Acute Ischaemic Stroke" (2 trials), "Acute Ischemic Stroke" (2 trials), "Myelofibrosis" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "The Affiliated Hospital of Inner Mongolia Medical University" in a lesser frequency.

Most popular intervention types in "The Affiliated Hospital of Inner Mongolia Medical University" are "Drug" (25 trials), "Other" (4 trials), "Genetic" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "MTX" (2 trials), "Placebo" (2 trials), "Recombinant human urokinase" (2 trials), "parsaclisib" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Affiliated Hospital of Inner Mongolia Medical University" are 33 trials for "All" genders.

Currently, there are NaN active trials in "The Affiliated Hospital of Inner Mongolia Medical University". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in The Affiliated Hospital of Inner Mongolia Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Affiliated Hospital of Inner Mongolia Medical University, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".